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ABSTRACT A medium consisting of a rich basal nutrient mixture supplemented with bovine
insulin (10 ,ug/ml), human transferrin (10 [Lg/ml), human cold-insoluble globulin (5 jAg/ml),
and ethanolamine (0.5 mM) supported the growth of the A431 human epidermoid cell line in
the absence of serum with a generation time equal to that of cells in serum-containing medium.
Addition of epidermal growth factor (EGF) to this culture medium at concentrations mitogenic
for other cell types resulted in a marked inhibition of A431 cell growth . Inhibitory effects of
EGF were observed at 1 ng/ml and near-maximal effects were observed at 10 ng/ml . The
inhibitory effect of EGF could be reversed by the omission of EGF in subsequent me-
dium changes and could be prevented by the addition of anti-EGF antibody to the culture me-
dium . Inhibition of A431 cell growth by EGF also could be demonstrated in serum-containing
medium .
Epidermal growth factor (EGF), a polypeptide originally iso-
lated from mouse submaxillary gland by Cohen (see reference
1), is a potent mitogen for a number of cell types in culture or
in vivo. The A431 human epidermoid carcinoma cell line has
been used in recent years as a model for the study of early
events after the interaction of EGF with its specific cell surface
receptor. These cells express an unusually large number ofhigh
affinity cell membrane receptors for EGF (2, 3) and have been
used to demonstrate internalization of EGF by whole cells (3-
6) and enhancement of protein phosphorylation in membrane
preparations treated with EGF (7-11). These cells also have
been used in experiments designed to identify and isolate the
EGF receptor (12-14), and in studies of rapid effects of EGF
on cell morphology (15, 16) and pinocytotic activity (17).
Although the A431 cell line is clearly an attractive model
system for the study ofEGF effects, no data have been reported
regarding the mitogenic potential of EGF for these cells, and
indications were that experiments designed to demonstrate
stimulation of cell growth upon the addition of EGF to A431
cells under common culture conditions had been unsuccessful
11).
Recent work from the laboratories of Sato and others (18,
19, and references cited therein) has established that for many
cell types it is possible to replace the usual serum supplement
in culture medium with specific combinations of nutrients,
hormones, and growth factors, binding proteins, and attach-
ment factors, and that the biological effects of hormones or
growth factors often may be better identified in such serum-
free media than in serum-containing media. Using this ap-
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proach, a serum-free medium was developed which supported
the growth of A431 cells as well as serum-containing medium.
It was expected that in this serum-free medium an enhancement
of cell growth due to EGF might be demonstrated. However,
the presence of EGF at concentrations mitogenic for other cell
types was found to be markedly inhibitory for the growth of
A431 cells in the serum-free medium. Subsequently, the inhi-
bition also was found to be easily demonstrablé in serum-
containing medium. A preliminary report of this work ap-
peared as an abstract in May 1981 (20).
MATERIALS AND METHODS
Materials
Powdered culture media were obtained from GIBCO Laboratories (Grand
Island Biological Co., Grand Island, N. Y.). Tissue culture plasticware was
obtained from Falcon International, Inc. (Chicago, Ill.). The following materials
were obtained from Sigma Chemical Co. (St. Louis, Mo.): crude trypsin, EDTA,
soybean trypsin inhibitor, bovine insulin, human transferrin, ethanolamine, and
HEPES. Fetal calf serum (FCS) was obtained from Reheis. Affinity-purified
rabbit anti-mouse EGF was obtained from LAREF. Mouse epidermal growth
factor, human cold-insoluble globulin, bovine fibroblast growth factor and par-
tially purified human platelet-derived growth factor were obtained from Collab-
orative Research, Inc. (Waltham, Mass.). Human cold-insoluble globulin ob-
tained from Bethesda Research Laboratories, Inc. (Rockville, Md.) was also
stimulatory for A431 cell growth in serum-free medium, if added either directly
to the medium or after pretreatment of the culture dishes. Amino acid analysis
by the vendor of the EGF used in the experiments described in this report (lot
1099-63) indicates an amino acid composition essentially identicalto the reported
amino acid composition of EGF (1). Six other lots of EGF obtained from
Collaborative Research were also inhibitory for the growth ofA431 cells, and no
lots were found to be inhibitory at concentrations as high as 250 ne/ml for thegrowth ofa number ofother human and nonhuman fibroblastic and epithelioid
cell lines and strains in serum-free medium. EGFpurified from mouse submax-
illary gland in the laboratory of Dr. Ralph Bradshaw (Washington University)
was as effective as the commercially available product at inhibiting A431 cell
growth. This EGF preparation was a gift of Dr. Gordon Sato (University of
California at San Diego) and was originally a gift to Dr. Sato from Dr. Bradshaw.
Cell Culture
A431 cells were a gift of Dr. T. Hunter (The Salk Institute). Thecell line was
originally established in the laboratory of Dr. G. Todaro (National Institutes of
Health) (2). Cultures were incubated in a 5% COz95%air atmosphere at 37°C
in a one-to-one mixture of Ham's F12 and Dulbecco-Modified Eagle's Medium
supplemented with 1.2 g of sodium bicarbonate per liter, 15 mM HEPES, and
antibiotics. Other medium supplements were as indicated in the text and figure
legends. For the initiation of experiments, cells were detached from stock flasks
with a solution of 0.1%a crude trypsin and 0.9 mM EDTA in phosphate-buffered
saline (PBS), suspended in an equal volume of0.1% soybean trypsin inhibitor in
medium, centrifuged out of suspension, and replated at 2.0 x 10" cells/35-mm
diameter plate in the appropriate media. Where indicated, bovine insulin, human
transferrin, human CIg, and ethanolamine were added directly to culture plates
containing 1 ml of medium as small volumes of sterile, 100-fold concentrated
stocks shortly before adding cells in a second milliliter ofmedium. Final concen-
trations were 10 pg/ml insulin, 10 pg/ml transferrin, 5 pg/ml CIg, and 0.5 mM
ethanolamine. EGFwas added as small volumes of sterile, concentrated stocks
togive indicated final concentrations. FCSwas added togive afinalconcentration
of 10%. For determination of cell number, cells were detached from plates with
the trypsin-EDTA-PBS solution and suspensions were counted in a Coulter
particle counter (Coulter Electronics, Inc. Hialeah, Fla.). Data shown are the
average ofdeterminations from duplicate plates. Individual samples did not vary
>I0% from the average.
RESULTS
Growth of A431 Cells in Serum-free Medium
The A431 cell line in culture usually is grown in Dulbecco's
modified Eagle's medium (DME) supplemented with 10% FCS
(2, 3, 12-14). Because other basal nutrient media, particularly
Ham's F 12 or mixtures of F 12 and DME, are superior to DME
in supporting growth of some cell lines (18, 19), an initial
survey of cell growth was carried out in F12, DME, or a one-
to-one mixture of F12 and DME (F12:DME) supplemented
with 0 to 10% human, horse, calf, newborn calf, or fetal calf
serum. Best growth was seen in F 12:DME supplemented with
10% FCS (F12:DME+FCS), and all stock cultures used in
these experiments were grown in this medium. 6 d after seeding
plates at a cell density of2.5 x 103/cm2, cell number in plates
containing F 12:DME+FCS was - í00 1o higher than cell number
in plates containing DME supplemented with 10% FCS.
Using F12:DME as the basal nutrient medium, about 40
supplements found to be stimulatory for growth of one or more
cell types in serum-free media (18, 19) were assayed for growth
stimulatory activity on A431 cells. Although most were inac-
tive, a few stimulatory supplements were identified. The most
active factors in promoting A431 cell growth in the absence of
serum were bovine insulin (2-201ug/ml), human transferrin (2-
20 ftg/ml), human cold-insoluble globulin (CIg) (2-10 tag/ml),
and ethanolamine (0.1-1 mM). Insulin, transferrin, and CIg
are common supplements in serum-free media (18, 19); etha-
nolamine and phosphoethanolamine previously have been re-
ported to be stimulatory for cell growth in culture (21). Small
increases in cell number were also seen in serum-free medium
supplemented with glycyl-histidyl-lysine (2 fyg/ml), and small,
inconsistent increases in cell numberwere sometimes seenupon
supplementation with parathyroid hormone (5 ng/ml) or so-
matostatin (100 ng/ml). These three factors were not included
in the serum-free media used in the studies described here.
CIg acts as an attachment factor for a number ofcell lines in
serum-free media (18, 19). As previously reported for other cell
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types (22-24), CIg also was effective if the plates into which
A431 cells were seeded were pretreated for 4 h with CIg-
containing medium and then washed with fresh medium before
adding cells. Under these conditions, CIg presumably adheres
to the culture dish and mediates the proper attachment ofcells
to the substratum. Serum spreading factor, a glycoprotein
isolated from human serum which is immunologically distinct
from CIg but which produces biological effects similar to those
of CIg in serum-free cell culture (25), also was effective on
A431 cells under these circumstances. Pretreatment of culture
dishes with polylysine (350,000 mol wt) by the method of
McKeehan and Ham (26) was not stimulatory for A431 cell
growth in serum-free medium.
In F 12:DME supplemented with 10 ,ug/ml insulin, 10 ltg/ml
transferrin, 5 Ag/ml CIg, and 0.5 mM ethanolamine (1712:
DME+4F), A431 cells grew with a generation time of -30 h,
a rate essentially identical to that of cells in F12:DME+FCS
(Fig. 1). After 6 d in culture, cell number in plates containing
F12:DME+4F was 90%-120% ofcell number in plates contain-
ing F12:DME+FCS. No further increase in cell number be-
yond that ofplates containing F12:DME+4F was seen in plates
containing F12:DME+4F supplemented with 10% FCS. Even
in plates containing F12:DME, without supplementation with
the four factors, A431 cells were capable of growth in the
absence of serum, although the generation time was longer
(-48 h), and the time lag before onset of growth after plating
was greater than that seen for cells in plates containing F12:
DME+4F. Medium changes at 72-h intervals did not decrease
the generation time of A431 cells in plates containing F12:
DME+4F compared to that seen under the conditions of Fig.
1, but did extend the period of exponential growth, so that a
density of 6 x 105 cells/cm' could be obtained in 12 d from
cultures seeded at 2.5 x 103 cells/cm2 (Fig. 2). A431 cultures
grown to confluence in F12:DME+4F could be trypsinized
and replated repeatedly in the same medium and have been











Growth of A431 cells in serum-containing or serum-free
medium in the presence or absence of EGF. F12:DME+FCS
(F~; F12:DME+4F
￿
F12:DME ("- "); F12:DME+4F
+ 10 ng/ml EGF (O-_O); F12:DME+4F + 100 ng/ml EGF (O--O);




Reversal of EGF inhibition of cell growth. Arrows indicate
days on which medium waschangedfor all conditions. F12:DME+4F
(9--"); F12:DME+4F + 10 ng/ml EGF (O - 0), F12:DME+4F
changed to F12:DME+4F + 10 ng/ml EGF on day 6 (O--O) ; F12:
DME+4F + 10 ng/ml EGF changed to F12:DME+4F on day 3Inhibition of A431 Cell Growth by EGF
Addition of 10 ng/ml mouse EGF to F12:DME+4F at the
time of cell plating resulted in an increase in both the genera-
tion time and the time lag before an increase in cell number
could be detected (Fig. 1). Addition of EGF at 100 ng/ml
resulted in an even greater inhibition ofgrowth; the cell number
6-8 d after seeding in plates containing F12:DME+4F with
100 ng/ml EGF was -10% of the cell number in plates
containing F 12:DME+4F. Inhibition ofgrowth in the presence
of EGF also could be demonstrated with cells in plates con-
taining F12:DME, without the supplements, or in plates con-
taining F12:DME+FCS.
It was not necessary to add EGF to the culture medium at
the time ofplating to demonstrate inhibition of growth: 10 ng/
ml EGF added to cells upon medium change 6 d after plating
in F12:DME+4F resulted in a decreased growth rate in the
subsequentdays ofculture (Fig. 2), although there was a lag of
several days before significant inhibition of cell growth due to
the addition of EGF could be observed, suggesting that under
the conditions of this experiment the effect of EGF on cell
growth was not rapid. Similarly, cells incubated for the first
three days afterseeding in F12:DME+4F containing 10 ng/ml
EGF and then changed to F 12:DME+4F without EGF re-
sumed growth with a generation time near that of cells not
exposed to EGF, but only after a lag of -3 d, during which the
effect of EGF was still quite evident.
An inhibitory effect of 1 ng/ml EGF could be demonstrated
on A431 cell growth; a near-maximal inhibitory effect was seen
at 10 ng/ml EGF (Fig. 3). At 10-100 ng/ml, morphological
effects of EGF were observed; cells were more rounded and
granular and assumed unusual, less uniform shapes than in
medium in the absence of EGF. Effects of EGF on A431 cell
morphology have been reported previously by Chinkers et al.
(15, 16). Several laboratories have explored the relationship
between cell shape and cell proliferation (25, 30, 31) and it may
be that the inhibitory effect of EGF on A431 cell growth may
be in some way related to the ability of EGF to induce cell
rounding.
Addition of affinity-purified rabbit anti-mouse EGF anti-
body to the culture medium was effective at preventing the
inhibition of cell growth caused by the addition of EGF (Fig.
4). This antibody in the same concentration range also was
effective at inhibiting the previously reported mitogenic effect
ofEGF for HeLa cellsin serum-free medium (data not shown)
(32). Addition of the preparation of anti-EGF antibody used
for the experiment of Fig. 4 to A431 cells at concentrations
>I0 ,ug/ml resulted in considerable inhibition of cell growth in
F 12:DME+4F. The remaining small inhibitory effect of EGF
EGF (ng/ml)
FIGURE 3 Concentration dependence of EGF inhibition of A431
cell growth. Cells were counted after incubation for 6 d in plates
containing F12:DME+4F with the indicated concentrations of EGF
(9
￿
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DISCUSSION




Prevention of EGF inhibition of A431 cell growth by anti-
EGF antibody. Cells were plated in F12:DME+4F in the presence of
anti-EGF at the indicated concentrations and the presence or ab-
sence of EGF at 10 ng/ml. Cells were counted 6 d after plating. F12:
DME+4F without EGF ("--") ; F12:DME+4F with EGF (o--O) .
in Fig. 4 in the presence of 10 pg/ml of the antibody presum-
ably was due to the presence of residual, free EGF which was
not bound to the antibody under the conditions of the experi-
ment. It is also possible that the EGF-antibody complex re-
tained some inhibitory activity for A431 cells.
EGF has been reported previously to be inhibitory for the
growth of GH3D6 and GH4 rat pituitary tumor cells in culture
(27, 28). It is interesting that, for both the A431 and GH lines,
EGF lengthened the generation time but was not toxic, because
incubation with EGF never resulted in fewer cells than were
present initially. Fibroblast growth factor (FGF) and thyrotro-
pin releasing hormone (TRH) are also inhibitory for growth of
GH4 cells (28). No effect of FGF at 50 ng/ml or TRH at 10
ng/ml was detected on A431 cells in serum-free medium, but
some inhibition of A431 growth was seen upon incubation of
cells in serum-free medium containing a partially purified
preparation of platelet-derived growth factor or 1 mM dibutryl
cyclic AMP. Because EGF is also capable of mediating differ-
entiated functions of some cell types (1, 27, 28), it is reasonable
to speculate that EGF may induce differentiatioe changes in
A431 cells in culture and that such effects may be associated
with the observed inhibition ofgrowth. No gross changes which
might be indicative of differentiation of an epidermoid cell
type, such as whole cell keratinization, were detected after
treatment of A431 cells with EGF. However, no detailed
biochemical or microscopy investigations of more subtle
markers of differentiation have been attempted.
The striking inhibition ofA431 cell growth by EGF suggests
that future attempts to relate effects of EGF on these cells to
mitogenic effects of EGF on other cell types in vitro or in vivo
should be approached with caution. However, it is unlikely
that the data of any of the existing reports dealing with the
biochemistry or cell biology of EGF effects on A431 cells
represent responses unrelated to the mitogenic effects of EGF,
because qualitatively similar effects may be demonstrated in
other cell culture systems in which the mitogenic potential of
EGF is well established.
Recently, Anderson et al. (29) have reported that A431 cells
express unusually large numbers of receptors for low density
lipoprotein (LDL) compared to other cell types examined in
culture. Furthermore, these investigators found that receptor-
mediated endocytosis of LDL by A431 cells is significantly
altered in several respects when compared with that of other
cell types studied in culture, such as diploid human fibroblasts.
D. W. BARNES
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EGF Inhibits A431 Cell Growth in Serum-free MediumThe availability of the serum-free medium described here for
the growth of the A431 cell line allows the design of experi-
ments in which the external environment of healthy, growing
cells may be controlled completely on a long-term basis. The
ability to manipulate the nature and concentration of nutrients,
hormones, lipoproteins or other components of the culture
medium in theabsenceofundefined serumcomponents should
provide numerous advantages to investigators interested in
studies related to the several useful and peculiar properties of
the A431 line (18, 19).
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A report by G. N. Gill and C. S. Lazar (1981.
Increased phosphotyrosine content and inhibition of proliferation in
EGF-treated A431 cells. Nature (Loud.). 293:305-307) ofinhibition of
proliferation in EGF-treated A-431 cellsin serum-containing medium
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